| (Values in U.S. Thousands) | Jun, 2017 | Jun, 2016 | Jun, 2015 | Jun, 2014 | Apr, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -20,280 | -14,940 | -11,360 | -9,730 | 0 |
| Net Income Growth | -35.74% | -31.51% | -16.75% | unch | unch |
Antriabio Inc (ANTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
AntriaBio, Inc. is a biopharmaceutical company. The company is engaged in developing therapeutic products for the diabetes market. AntriaBio, Inc. is based in Menlo Park, California.